Xterminate may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Chlorpyrifos is reported as an ingredient of Xterminate in the following countries:
International Drug Name Search
Paramidol may be available in the countries listed below.
Paracetamol is reported as an ingredient of Paramidol in the following countries:
International Drug Name Search
Insulin Human Mixtard may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Insulin Injection, Biphasic Isophane human (a derivative of Insulin Injection, Biphasic Isophane) is reported as an ingredient of Insulin Human Mixtard in the following countries:
International Drug Name Search
Orozim may be available in the countries listed below.
Pancreatin is reported as an ingredient of Orozim in the following countries:
International Drug Name Search
Use Dexmethylphenidate Extended-Release Capsules with caution if you have a history of emotional problems or alcohol or substance abuse. Abuse of Dexmethylphenidate Extended-Release Capsules may cause it to not work as well. Abuse may also lead to addiction and severe mental changes. Do not suddenly stop using Dexmethylphenidate Extended-Release Capsules. Depression and other mental problems may occur. Your doctor should slowly lower your dose over a period of time if you need to stop using it.
Treating attention deficit hyperactivity disorder (ADHD). It may also be used for other conditions as determined by your doctor.
Dexmethylphenidate Extended-Release Capsules are a central nervous system stimulant. Exactly how it works is not known.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Dexmethylphenidate Extended-Release Capsules. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Dexmethylphenidate Extended-Release Capsules. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Dexmethylphenidate Extended-Release Capsules may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Dexmethylphenidate Extended-Release Capsules as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Dexmethylphenidate Extended-Release Capsules.
When used for long periods of time or at high doses, Dexmethylphenidate Extended-Release Capsules may not work as well and may require higher doses to obtain the same effect as when originally taken. This is known as TOLERANCE. Talk with your doctor if Dexmethylphenidate Extended-Release Capsules stops working well. Do not take more than prescribed.
Some people who use Dexmethylphenidate Extended-Release Capsules for a long time may develop a need to continue taking it. People who take high doses are also at risk. This is known as DEPENDENCE or addiction. Do not suddenly stop taking Dexmethylphenidate Extended-Release Capsules. If you stop taking Dexmethylphenidate Extended-Release Capsules suddenly, you may have WITHDRAWAL symptoms. These may include depression or other mental problems.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Anxiety, dizziness; drowsiness; dry mouth; headache; indigestion; loss of appetite; nausea; nervousness; stomach pain; trouble sleeping.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; joint pain; purple or brownish red spots on the skin); behavior changes (eg, aggression, hostility, restlessness); blurred vision or other vision problems; chest pain; confusion; dark urine; fainting; fast or irregular heartbeat; fever, chills, or sore throat; hallucinations; mental or mood changes (eg, agitation, depression, irritability, panic attacks, persistent crying, severe or persistent anxiety, unusual sadness); one-sided weakness; seizures; severe or persistent dizziness or headache; shortness of breath; slurred speech; suicidal thoughts or attempts; tremor; uncontrolled speech or muscle movements; yellowing of the eyes or skin.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Dexmethylphenidate side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include confusion; dilated pupils; fast or irregular heartbeat; fever; flushing; hallucinations; loss of consciousness; muscle twitching; seizures; severe or persistent headache or vomiting; tremors; unusual sweating.
Store Dexmethylphenidate Extended-Release Capsules at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dexmethylphenidate Extended-Release Capsules out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Dexmethylphenidate Extended-Release Capsules. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Insulin Humodar R may be available in the countries listed below.
Insulin Injection, Soluble human (a derivative of Insulin Injection, Soluble) is reported as an ingredient of Insulin Humodar R in the following countries:
International Drug Name Search
Procanin may be available in the countries listed below.
Procaine hydrochloride (a derivative of Procaine) is reported as an ingredient of Procanin in the following countries:
International Drug Name Search
Enalapril Almus may be available in the countries listed below.
Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalapril Almus in the following countries:
International Drug Name Search
Prépacol may be available in the countries listed below.
Bisacodyl is reported as an ingredient of Prépacol in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Rec.INN
0071109-09-6
C19-H22-O2
282
Analgesic, antipyretic and anti-inflammatory agent
Non-steroidal anti-inflammatory drug, NSAID
(+/-)-4-Cyclohexyl-alpha-methyl-1-naphthaleneacetic acid (WHO)
(RS)-2-(4-Cyclohexyl-1-naphthyl)propionic acid (BAN)
Naphthaleneacetic acid, 4-cyclohexyl-alpha-methyl-, (+/-)- (USAN)
International Drug Name Search
Glossary
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Hydrocortison-POS may be available in the countries listed below.
Hydrocortisone 21-acetate (a derivative of Hydrocortisone) is reported as an ingredient of Hydrocortison-POS in the following countries:
International Drug Name Search
Kalmol may be available in the countries listed below.
Acetylsalicylic Acid is reported as an ingredient of Kalmol in the following countries:
Caffeine is reported as an ingredient of Kalmol in the following countries:
International Drug Name Search
